50% of cases merge with chronic diseases, the White Paper on Comprehensive Prevention and Treatment of Glaucoma is released: Glaucoma in China is becoming a younger system | Patients | China

Release time:Apr 13, 2024 20:40 PM

Tomorrow is the 28th National Eye Care Day, and this year's theme is "Pay attention to universal eye health". Recently, guided by the Medical Affairs Department of the National Health Commission and the National Blindness Prevention Technology Guidance Group, and organized by the Shanghai Municipal Health Commission and the Shanghai Blindness Prevention Technology Guidance Group, the Shanghai Blindness Prevention Technology Guidance Group released the "White Paper on Comprehensive Prevention and Treatment Management of Glaucoma". The white paper shows that primary glaucoma is the main cause of glaucoma in China, and the disease is age-related but shows a trend of youthfulness, with no significant gender differences.

Glaucoma, as the world's first irreversible blinding eye disease, seriously impairs the visual function of patients. China is one of the countries with the highest number of blind and visually impaired patients in the world. The prevalence of glaucoma in the Chinese population is 2.58%, accounting for about a quarter of the world's glaucoma patients, and the number of blind people is 5.67 million.

Professor Sun Xinghuai, the appointed chairman of the Ophthalmology Branch of the Chinese Medical Association and the affiliated Eye, Ear, Nose and Throat Hospital of Fudan University, said that most cases of glaucoma are chronic and insidious, making early diagnosis difficult. At the same time, a large number of patients lack awareness of the disease, and two-thirds of glaucoma patients have already progressed to the middle and late stages at the initial diagnosis. The delayed diagnosis rate of glaucoma in developed countries reaches 50%, while in developing countries, the delayed diagnosis rate can reach 90%.

Exploring a comprehensive management model for glaucoma prevention and treatment that integrates prevention, screening, and management, the Shanghai Eye Disease Prevention and Treatment Center and Fudan University Affiliated Eye, Ear, Nose and Throat Hospital jointly initiated the project. Led by two experts, Professor Sun Xinghuai and Professor Zou Haidong, and in collaboration with clinical and public health experts from various regions across the country, the White Paper Project on Comprehensive Prevention and Treatment of Glaucoma was officially launched in June last year.


50% of cases merge with chronic diseases, the White Paper on Comprehensive Prevention and Treatment of Glaucoma is released: Glaucoma in China is becoming a younger system | Patients | China

The survey lasted for 48 days and covered 33 hospitals in 6 provinces in the eastern, central, and western regions of China. The surveyed patients come from 27 provinces and municipalities across the country, with 130 cities/regions under their jurisdiction. A total of 1933 valid survey questionnaires were collected.

Research has found that primary glaucoma is the main type of glaucoma, and the disease is age-related but shows a trend towards younger age groups, with no significant gender differences. The proportion of comorbidities between glaucoma and other chronic diseases is high: 56.54% of glaucoma patients have other chronic diseases. It is of practical significance to incorporate glaucoma, hypertension and diabetes into physical examination and monitoring management, and to build a medical system that combines AI with medical union hierarchical diagnosis and treatment, which will help promote the sharing of medical and health resources.

The pressure on grassroots diagnosis and treatment of glaucoma is high, and the diagnostic and treatment capabilities and medical resources are insufficient. The burden of glaucoma disease and treatment is heavy, and patients need to improve their disease awareness, treatment compliance, and quality of life. Implementing community management for glaucoma patients can significantly improve follow-up compliance and patient quality of life.

Experts say that the diagnosis and treatment of glaucoma has always been a hot and difficult topic in the field of ophthalmology. Establishing a management model for chronic glaucoma patients, reducing the burden and disability rate of glaucoma, and continuously promoting the construction of ophthalmology related medical consortia should become a new model and trend for comprehensive prevention and treatment of glaucoma in China.


50% of cases merge with chronic diseases, the White Paper on Comprehensive Prevention and Treatment of Glaucoma is released: Glaucoma in China is becoming a younger system | Patients | China

At the event, the Eye, Ear, Nose and Throat Hospital affiliated with Fudan University released a survey report on the prevention and control of myopia in children and adolescents in 2023. The results from multiple centers presented the current situation of myopia prevention and control knowledge, beliefs, and behaviors among parents from different regions in China, providing the latest data support for the deepening of myopia prevention and control scientific concepts in schools and families.

Fan Xianqun, Academician of the CAE Member, Vice President of Shanghai Jiaotong University, Dean of the School of Medicine of Shanghai Jiaotong University, Wang Ningli, Leader of the National Blindness Prevention Technical Steering Group, Sun Xinghuai, Candidate Chairman of the Ophthalmology Branch of the Chinese Medical Association, Professor of the Ophthalmology, Otolaryngology Hospital Affiliated to Fudan University, Zou Haidong, Director of the Shanghai Blindness Prevention Office, President of the Shanghai Eye Disease Prevention and Treatment Center, Zhou Xingtao, President of the Ophthalmology, Otolaryngology Hospital Affiliated to Fudan University, Vice President of the Ophthalmology and Optometry Hospital Affiliated to Wenzhou Medical University, and Chen Wei, President of the Ningbo Ophthalmology Hospital, six ophthalmologists' representatives sent out an initiative to care for children and adolescents, care for the eye health, cataracts, glaucoma, fundus diseases and other key eye diseases, promote appropriate technologies for eye disease prevention and treatment, publicize eye care science, and provide eye health throughout the life cycle.

More than 100 parent-child families participated in a fun eye friendly outdoor health run by the Huangpu River on the same day. Renowned ophthalmologists from more than ten municipal hospitals in Shanghai provided on-site free consultations for citizens.

Why is "Cancer King" immunotherapy ineffective? Fudan Cancer Hospital Reveals New Mechanisms of Immunosuppressive Environment for pancreatic cancer CRIP1 | Tumor | pancreatic cancer
Why is "Cancer King" immunotherapy ineffective? Fudan Cancer Hospital Reveals New Mechanisms of Immunosuppressive Environment for pancreatic cancer CRIP1 | Tumor | pancreatic cancer

Immunotherapy has been proven to achieve significant therapeutic effects in various solid tumors. However, for pancreatic cancer, known as the "king of cancer", immunotherapy has been ineffective. On August 4, Professor Yu Xianjun, Dean of the Cancer Hospital Affiliated to Fudan University, and Shi Si, Associate Professor of Pancreatic Surgery released a research achievement, which first found the key role of cysteine rich protein 1 in shaping the immunosuppressive microenvironment of pancreatic cancer, filled the gap in the research field of immunosuppressive microenvironment of pancreatic cancer, and provided a theoretical basis for precise immunotherapy of pancreatic cancer patients. Ductal adenocarcinoma of the pancreas is the main type of pancreatic cancer, accounting for about 90% of all pancreatic cancer. Due to its high malignancy and poor treatment effectiveness, pancreatic ductal adenocarcinoma has always been one of the most malignant tumors. In recent years, the level of surgical techniques and comprehensive treatment has been achieved

A 14-year-old girl suffers from a rare eye disease and receives support from a public welfare fund. Symptoms of "I haven't looked in the mirror for a long time" | Patient | Public welfare
A 14-year-old girl suffers from a rare eye disease and receives support from a public welfare fund. Symptoms of "I haven't looked in the mirror for a long time" | Patient | Public welfare

A 14-year-old girl has been experiencing symptoms such as protruding pupils, incomplete eye closure, corneal injury, restricted eye movement, and overall fatigue for several years. The physical discomfort and facial abnormalities caused by eye diseases have made her increasingly reticent, and her temperament is vastly different from before. At the Ophthalmology Department of the Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, the pupil has been diagnosed with a rare thyroid ophthalmopathy combined with myasthenia gravis, which requires prompt treatment. However, considering the young age of the pupil, conventional hormone and radiation therapy cannot be used. Therefore, Zhou Huifang, Deputy Director of Ophthalmology and thyroid ophthalmology expert, has developed a targeted drug combined with surgical treatment plan for it, and targeted drug treatment will be performed first. Three months ago, I was hospitalized for one week with mydriasis and received intravenous targeted drug treatment. Afterwards, I went home for observation and followed up on time

The municipal eye disease prevention and treatment center launched the dry eye diagnosis and treatment studio, and the incidence rate of dry eye in China is about 21% to 30% of the meibomian gland | dry eye | eye disease
The municipal eye disease prevention and treatment center launched the dry eye diagnosis and treatment studio, and the incidence rate of dry eye in China is about 21% to 30% of the meibomian gland | dry eye | eye disease

According to the Statistics of Chinese Dry Eye Expert Consensus, the incidence rate of dry eye in China is about 21%~30%, and it is estimated that there are at least 300 million patients nationwide. The Dry Eye Diagnosis and Treatment Studio of Shanghai Eye Disease Prevention and Treatment Center was officially launched today. In the future, the studio will continuously improve the dry eye diagnosis and treatment standards, and form standardized diagnosis and treatment concepts and service models. Suitable technologies will be promoted to the community, allowing residents to enjoy convenient dry eye diagnosis and treatment services at their doorstep. Executive Dean and Party Secretary Gao Wei stated that this is also one of the livelihood service measures recently launched by the hospital around high-quality development and meeting the needs of the people. It is reported that dry eye syndrome is a chronic ocular surface disease caused by multiple factors. The instability of the tear film or imbalance of the ocular surface microenvironment caused by abnormal quality, quantity, and dynamics of tears can be accompanied by ocular surface inflammatory reactions, tissue damage, and nerve abnormalities, resulting in various discomforts in the eyes

The Ninth Hospital has taken the lead in formulating the world's first consensus on core indicators for clinical evaluation of dental implants, which has been officially published in clinical practice
The Ninth Hospital has taken the lead in formulating the world's first consensus on core indicators for clinical evaluation of dental implants, which has been officially published in clinical practice

The International Dental Implant Consensus Report, jointly written by the Ninth People's Hospital affiliated with Shanghai Jiao Tong University School of Medicine and renowned universities in the field of dentistry such as Harvard University, University of Zurich, University of Gothenburg, Columbia University, and University of Frankfurt, has recently been jointly published in top journals in the field of dentistry, including Clinical Periodontology and Clinical Dental Implant Research. This consensus has for the first time established an internationally unified core set of indicators for evaluating the clinical effectiveness of dental implants, covering the five key areas of the field of dental implants. It is of milestone significance for carrying out standardized clinical diagnosis, treatment, and research on dental implants. The core evaluation indicators determined by this consensus will become an important benchmark for scholars in the field of dental implants worldwide to conduct high-quality research. The consensus is composed of 8 top international experts in the field of oral implantation

Recently, autologous hematopoietic stem cell therapy was completed in Shanghai, and British girls born in the 1990s have suffered from multiple relapses of blood diseases, including stem cells, peripheral blood, and diseases
Recently, autologous hematopoietic stem cell therapy was completed in Shanghai, and British girls born in the 1990s have suffered from multiple relapses of blood diseases, including stem cells, peripheral blood, and diseases

Recently, Catherine, a British girl born in the 1990s, received autologous peripheral blood hematopoietic stem cell transfusion at the Cancer Center of Shanghai Jiahui International Hospital, and was successfully discharged from the warehouse. She is now on her way back to China after being discharged from the hospital. She is also the first patient at Shanghai Jiahui International Hospital to complete relevant treatments. In 2019, Catherine was diagnosed with Hodgkin's lymphoma in the UK, and after treatment, the disease completely improved. During her work and life in China in 2021, she went to seek medical attention due to multiple enlarged lymph nodes. Pathological biopsy confirmed a recurrence of Hodgkin's lymphoma, and through combined targeted drug treatment, her condition was temporarily under control. Last year in the second half of the year, when the disease recurred, the girl began to use immunotherapy combined with targeted drugs for treatment. Expert evaluation suggests that for young patients with hematological tumors, the risk of recurrence is high and treatment difficulty is increasing in the future. Autologous hematopoietic stem cell therapy is recommended